{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:25:38Z","timestamp":1789885538933,"version":"4.0.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.bmc.2004.03.035","type":"journal-article","created":{"date-parts":[[2004,4,13]],"date-time":"2004-04-13T05:30:59Z","timestamp":1081834259000},"page":"2517-2521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs"],"prefix":"10.1016","volume":"12","author":[{"given":"Xue Wu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Leng","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2004.03.035_BIB1","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/jama.290.13.1695","article-title":"Old drugs for a new bug","volume":"290","author":"Vastag","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bmc.2004.03.035_BIB2","doi-asserted-by":"crossref","unstructured":"Bonanno, J. B.; Fowler, R.; Gupta, S.; Hendle, J.; Lorimer, D.; Romero, R.; Sauder, M.; Wei, C. L.; Liu, E. T.; Burley, S. K.; Harris, T. X-ray Crystal Structure of the SARS Coronavirus Main Protease, to be published (http:\/\/www.rcsb.org\/pdb\/cgi\/explore.cgi?pdbId=1Q2W), 2003","DOI":"10.2210\/pdb1q2w\/pdb"},{"key":"10.1016\/j.bmc.2004.03.035_BIB3","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bmc.2004.03.035_BIB4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1046\/j.1432-1327.2002.02811.x","article-title":"Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant","volume":"269","author":"Lindberg","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bmc.2004.03.035_BIB5","doi-asserted-by":"crossref","first-page":"14394","DOI":"10.1021\/bi981309m","article-title":"Crystal structures of HIV-1 reverse transcriptase in complex with carboxanilide derivatives","volume":"37","author":"Ren","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2004.03.035_BIB6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/prot.10379","article-title":"Evaluation of protein docking predictions using Hex 3.1 in CAPRI rounds 1 and 2","volume":"52","author":"Ritchie","year":"2003","journal-title":"Proteins: Struct. Funct. Genet."},{"key":"10.1016\/j.bmc.2004.03.035_BIB7","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1093\/nar\/gkg571","article-title":"LGA: a method for finding 3D similarities in protein structures","volume":"31","author":"Zemla","year":"2003","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.bmc.2004.03.035_BIB8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0006-291X(03)01342-1","article-title":"Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS","volume":"308","author":"Chou","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bmc.2004.03.035_BIB9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6807-3-2","article-title":"Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations","volume":"3","author":"Jenwitheesuk","year":"2003","journal-title":"BMC Struct. Biol."},{"issue":"22","key":"10.1016\/j.bmc.2004.03.035_BIB10","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1016\/j.bmcl.2003.08.066","article-title":"Identifying inhibitors of the SARS coronavirus proteinase","volume":"13","author":"Jenwitheesuk","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5626","key":"10.1016\/j.bmc.2004.03.035_BIB11","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bmc.2004.03.035_BIB12","first-page":"399","article-title":"Treatment of severe acute respiratory syndrome with lopinavir\/ritonavir: a multicentre retrospective matched cohort study","volume":"9","author":"Chan","year":"2003","journal-title":"Hong Kong Med. J."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089604002214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089604002214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:43:45Z","timestamp":1760827425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089604002214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0968089604002214"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2004.03.035","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2004.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}